PMED — Piu Medical Income Statement
0.000.00%
- €40.30m
- €37.89m
- €6.62m
Annual income statement for Piu Medical, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 25 | 26.1 | 6.62 |
| Cost of Revenue | |||
| Gross Profit | 6.38 | 6.1 | 1.84 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 22.3 | 23.7 | 6.48 |
| Operating Profit | 2.68 | 2.37 | 0.137 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 1.95 | 1.67 | -0.062 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 1.48 | 1.25 | -0.04 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | 1.48 | 1.25 | -0.044 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 1.48 | 1.25 | -0.044 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 0.221 | 0.233 | 0.014 |